The Endogenous Cannabinoids and the Control of Drug Craving Alexandros Makriyannis, Director.

Slides:



Advertisements
Similar presentations
Overview of the striatum
Advertisements

E.4 Neurotransmitters and Synapses. E4.1 Postsynaptic Responses Pre-synaptic neurons can inhibit or excite the post synaptic neuron by releasing excitatory.
1 Vol. 01. p Vol. 01. p Vol. 01. p.20.
1 Vol. 03. p Vol. 03. p Vol. 03. p.21.
1 Vol. 02. p Vol. 02. p Vol. 02. p.19.
1 Vol. 03. p Vol. 03. p Vol. 03. p.16.
1 Vol. 02. p Vol. 02. p Vol. 02. p.30.
1 Vol. 03. p Vol. 03. p Vol. 03. p.35.
1 Vol. 02. p Vol. 02. p Vol. 02. p.10.
1 Vol. 01. p Vol. 01. p Vol. 01. p.14.
Revised Model of Endocannabinoid Signaling. Cannabinoids Medically and traditionally used for thousands of years Active compound of marijuana (D 9 -THC)
Figure 3.16 Different Types of Synaptic Connections
Psych 181: Dr. Anagnostaras Lec 10: Marijuana. cannabinoids Marijuana and cannabinoids Cannabis sativa, hemp One of earliest non-food plants cultivated.
Efficacy in CB 1 Cannabinoid Receptor Signal Transduction. NIDA November, 2003 Allyn Howlett, Ph.D. Neuroscience/Drug Abuse Research Program J. L. Chambers.
Effects of Cannabanoids on the brain! Delta 9-THC.
Source: International Chair on Cardiometabolic Risk Role of the Dysregulated Endocannabinoid System in Determining Cardiometabolic.
Drugs. Say _Know_ to. Food Vitamins Minerals Aspirin Chocolate Coffee Alcohol Nicotine.
CHOCOLATE How It affects the human body. Popularity  The average American citizen eats over 12 pounds of chocolate per year  Chocolate Industry claims.
CB1 expression in DRGs. Pharmacological tools Selectivity and affinity of CB1 agonists are suboptimal (Pertwee 2009)
Neurotransmitters (and other Mood Changers). All Natural – All Organic Neurotransmitters responsible for: reward pathways, mood, sleep, muscle control,
Receptors and transduction 2 References: Chapter 12 – Neuron by Levitan & Kaczmarek OR Chapter 6 – Neuroscience by Purves et al 1)Metabotropic glutamate.
Endocannabinoids An Emotional Buffer?.  Lipid neuromodulators and hormones  Made from Membrane phospholipids  Synthesized On Demand   stimulated.
Cannabinoid use in Cancer Patients PAS 646 Univ. of Kentucky Ryan Filiatreau.
Exercise and pain Walter R. Frontera, MD, PhD Professor and Chair (Inaugural) Department of Physical Medicine and Rehabilitation Vanderbilt University.
A cannabinoid hypothesis of Schizophrenia Cognitive Impairments Due to Dysregulation of the Endogenous Cannabinoid System.
Cannabis: The plants used for making marijuana Plant features Annual Dioecious Flowering Wind-pollinated.
E4: Neurotransmitters and Synapses DnlNjuguna ~ DAIS.
Endocannabinoid signaling and stress in CVS Thangam Venkatesan, MD Associate Professor of Medicine Division of Gastroenterology and Hepatology Medical.
The Endocannabinoid System as a Pharmacologic Target in Treating Obesity Lauren Kerrick Braden Advisor: Dr. Hadley Spring 2007.
Research themes 1.Describe the main scientific question and the big scientific picture you address. 2.Why is it important? 3.The knowledge gap (i.e. unanswered.
Mechanisms of Endocannabinoid Inactivation: Functional Consequences Daniele Piomelli University of California, Irvine SfN, November 7, 2003.
Medical Marijuana Helen Jang, Tara Hooley, David Hoang, Noel Kwok, John K Rhee, & Janelle Odakura DFM 655 Fall 2014.
Spinal Endocannabinoids and CB 1 Receptors Mediate C-Fiber–Induced Heterosynaptic Pain Sensitization Pernia-Andrade et al. (2009) Science 325:
Chapter 14 Opener State initiatives such as the 2012 Oregon Cannabis Tax Act are aimed at decriminalizing or even legalizing the possession and use of.
Cannabis and Schizophrenia. Major Constituents of Cannabis The two major substances found in cannabis include tetrahydrocannabinol (THC) and cannibidiol.
Drug Types Types –Psychoactive – alters mood or consciousness; affects neural functioning –Non-psychoactive – e.g., antibacterial Classes of psychoactive.
Marijuana-The Basics marijuana+works&n=780d08af&p2=^Y6^xdm003^S11497^us& pn=2&ptb=824B6CAC-6C85-494C-8E43-
The Nervous System-Part II
Potential Pharmacotherapy for Cannabis Use Disorders Leslie H. Lundahl, Ph.D. Department of Psychiatry and Behavioral Neurosciences Wayne State University.
The Nervous System-Part II Neurotransmitters, Drugs and Disease of the Brain.
A Drug from the Cannabis Field Appears to Protect From Seizure Related Brain Damage Long C 1, Quizon PMP 1, Romine H 1, Kelly W 1, Naidoo V 1, Ruiz S 1,
ENDOCANNABINOID REGULATION OF ALTERNATIVE MICROGLIA ACTIVATION IN MULTIPLE SCLEROSIS CAITLIN JAGLA.
Cannabis In Cancer Care
Cannabis in medicinal use
Synthesis of Dibenzofuran Analogues
Medical Cannabis Information for Medical Professionals and Patients from the Missouri Cannabis Nurses Association Copyright © 2017.
Pharmacology II Tutoring: Drugs of abuse & alcohol
Marijuana (MJ): Medicinal or Malevolent?
Medical Cannabis Dr. Andrea Burry MSc MD CCFP
Copyright © 2015 by the American Osteopathic Association.
Cannabinoid-Receptor Interacting Protein 1a (CRIP1a) effects on CB1 Inverse Agonists Erin Cochran.
Physiology of some additive drugs
Physiology and Pharmacology of Cannabis
Drugs that activate Gio-proteins receptors
Volume 49, Issue 1, Pages (January 2006)
CNS Pharmacology Dr. Hiwa K. Saaed,
Introduction to CNS pharmacology
Synthetic Cannabinoids Laboratory Perspective
Therapeutic potential of cannabis in pain medicine†
Cannabinoid signaling and liver therapeutics
Information needed for calculations
Volume 17, Issue 10, Pages (October 2010)
Hippocampus? OR....
Neurobiology/ Behavior Lesson
CBD & PREGNANCY When a woman becomes pregnant, everything she comes into contact with can potentially affect.
Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The.
2-AG + 2 New Players = Forecast for Therapeutic Advances
Volume 15, Issue 11, Pages (November 2008)
Clinicians’ Guide to Cannabidiol and Hemp Oils
Presentation transcript:

The Endogenous Cannabinoids and the Control of Drug Craving Alexandros Makriyannis, Director

 9 /  8 -THC  9 -THC /  8 -THC  9 -tetrahydrocannabinol  8 -tetrahydrocannabinol

Medicinal Uses for Cannabinoids AnalgesicAnticonvulsiveSedativeAntidepressiveHypnoticAntiasthmaticImmunomodulation Memory Enhancing Anesthetic Birth Control Appetite Stimulation Antipyretic Neuropathic Pain AntiemeticAntirheumaticAntimigraineAntineuralgic Reduction of Fatigue

Two Cannabinoid Receptors: CB1 & CB CB2 e1 e2 e3 i1 i2 i3 Extracellular 472 amino acids 360 amino acids

Endogenous Cannabinoid Receptor Ligands Anandamide2-Arachidonylglycerol Palmitylethanolamide CB CB1CB2CB1 K i (nM)

Cannabinoid Targets for Drug Discovery

Nature Neuroscience, Vol. 2, 4, (1999)

Retrograde Signaling & the Cannabinergic System

Purification of FAAH MW: 63 kDaMW: 63 kDa pI: 6.2pI:

Inhibition of [ 3 H]anandamide accumulation by AM 404 and AM403 Science, Vol. 277, (1997) AM404 AM403

Pharmacological Tools

Cannabinergic Ligands O N H OH AM 251 Anandamides (AEA’s) AM356 1,5-Biarylpyrazoles  8 -THC Aminoalkylindoles(AAI’s) Non-Classical (NCC’s) AM630 OH OH O H Classical (CC’s) CP55,940